SYBLEU INC (SYBE)
USD 0.06
(34.15%)
USD 0.06
(34.15%)
| Year | Total Assets | Total Assets Growth |
|---|---|---|
| 2022 | 330.46 Thousand USD | 332.67% |
| 2021 | 76.37 Thousand USD | -61.72% |
| 2020 | 199.54 Thousand USD | 2233.88% |
| 2019 | 8550.00 USD | 0.0% |
| Year | Total Assets | Total Assets Growth |
|---|---|---|
| 2023 Q3 | 313.7 Thousand USD | -5.07% |
| 2023 Q2 | 330.46 Thousand USD | 868.77% |
| 2023 Q1 | 34.11 Thousand USD | -44.08% |
| 2023 Q4 | 304.15 Thousand USD | -3.04% |
| 2022 Q4 | 60.99 Thousand USD | 7.26% |
| 2022 Q3 | 56.86 Thousand USD | 0.0% |
| Name | Total Assets | Total Assets Difference |
|---|---|---|
| Burzynski Research Institute, Inc. | 2310.00 USD | -14205.974% |
| Arch Therapeutics, Inc. | 1.95 Million USD | 83.124% |
| Evofem Biosciences, Inc. | 10.55 Million USD | 96.869% |
| Nascent Biotech, Inc. | 552.12 Thousand USD | 40.146% |
| Rebus Holdings, Inc. | 5000.00 USD | -6509.36% |
| Santhera Pharmaceuticals Holding AG | 130.21 Million USD | 99.746% |
| Qrons Inc. | 420.00 USD | -78582.857% |
| Adynxx, Inc. | - USD | -Infinity% |
| Neon Bloom, Inc. | 770.64 Thousand USD | 57.118% |
| Northwest Biotherapeutics, Inc. | 27.94 Million USD | 98.817% |
| ProtoKinetix, Incorporated | 480.55 Thousand USD | 31.232% |
| Skye Bioscience, Inc. | 11.94 Million USD | 97.232% |
| Eiger BioPharmaceuticals, Inc. | 38.84 Million USD | 99.149% |
| Nanobac Pharmaceuticals, Incorporated | 7.21 Million USD | 95.423% |
| Institute of Biomedical Research Corp. | 76.35 Thousand USD | -332.81% |
| SQZ Biotechnologies Company | 107.18 Million USD | 99.692% |
| Intellipharmaceutics International Inc. | 1.43 Million USD | 76.923% |
| Propanc Biopharma, Inc. | 72.36 Thousand USD | -356.668% |
| Mesoblast Limited | 667.9 Million USD | 99.951% |
| Marizyme, Inc. | 22.01 Million USD | 98.499% |
| Genus plc | 1.02 Billion USD | 99.968% |
| VioQuest Pharmaceuticals, Inc. | 1.35 Million USD | 75.671% |
| Pharming Group N.V. | 462.85 Million USD | 99.929% |
| Therapeutic Solutions International, Inc. | 3.31 Million USD | 90.025% |
| CNBX Pharmaceuticals Inc. | 499.03 Thousand USD | 33.779% |
| Nymox Pharmaceutical Corporation | 627 Thousand USD | 47.294% |
| ContraFect Corporation | 20.67 Million USD | 98.402% |
| PsyBio Therapeutics Corp. | 390.36 Thousand USD | 15.344% |
| Sienna Biopharmaceuticals, Inc. | - USD | -Infinity% |
| RegeneRx Biopharmaceuticals, Inc. | 382.17 Thousand USD | 13.53% |
| IMV Inc. | 31.33 Million USD | 98.945% |
| AXIM Biotechnologies, Inc. | 4.14 Million USD | 92.029% |
| MultiCell Technologies, Inc. | 126.22 USD | -261719.046% |
| ONE Bio Corp. | 70.08 Million USD | 99.528% |
| Accustem Sciences Inc. | 939.68 Thousand USD | 64.832% |
| RVL Pharmaceuticals plc | 128.51 Million USD | 99.743% |
| Arno Therapeutics, Inc. | - USD | -Infinity% |
| EV Biologics, Inc. | 431.71 Thousand USD | 23.452% |
| Q BioMed Inc. | 3.51 Million USD | 90.6% |
| Emmaus Life Sciences, Inc. | 35.17 Million USD | 99.061% |
| Mosaic ImmunoEngineering Inc. | 261.27 Thousand USD | -26.482% |
| Biomind Labs Inc. | 73.81 Thousand USD | -347.673% |
| American Oriental Bioengineering, Inc. | 446.3 Million USD | 99.926% |
| Provectus Biopharmaceuticals, Inc. | 1.44 Million USD | 77.191% |
| TetraLogic Pharmaceuticals Corporation | - USD | -Infinity% |
| Oncotelic Therapeutics, Inc. | 30.01 Million USD | 98.899% |
| GlobeStar Therapeutics Corporation | - USD | -Infinity% |
| THC Farmaceuticals, Inc. | 2.74 Million USD | 87.967% |
| Acro Biomedical Co., Ltd. | 687.48 Thousand USD | 51.931% |
| Curative Biotechnology, Inc. | 2.6 Million USD | 87.305% |
| GB Sciences, Inc. | 103.44 Thousand USD | -219.472% |
| Alpha Cognition Inc. | 2.45 Million USD | 86.523% |
| HST Global, Inc. | 1526.00 USD | -21555.832% |
| CSL Limited | 38.02 Billion USD | 99.999% |
| Wesana Health Holdings Inc. | 987.96 Thousand USD | 66.551% |
| Halberd Corporation | 10.13 Thousand USD | -3161.948% |
| Enzolytics Inc. | 361.7 Million USD | 99.909% |
| Agentix Corp. | 261.39 Thousand USD | -26.426% |
| Resverlogix Corp. | 8.11 Million USD | 95.928% |
| Nuo Therapeutics, Inc. | 1.87 Million USD | 82.402% |
| MetaStat, Inc. | - USD | -Infinity% |
| argenx SE | 4.54 Billion USD | 99.993% |
| Enzon Pharmaceuticals, Inc. | 47.7 Million USD | 99.307% |
| Endonovo Therapeutics, Inc. | 639.65 Thousand USD | 48.337% |
| RespireRx Pharmaceuticals Inc. | 22.78 Thousand USD | -1350.63% |
| GeneThera, Inc. | - USD | -Infinity% |
| Inhibitor Therapeutics, Inc. | 8.94 Million USD | 96.307% |
| AVAX Technologies, Inc. | 7.37 Million USD | 95.52% |
| Zenith Capital Corp. | 7410.00 USD | -4359.757% |
| Genscript Biotech Corporation | 3.38 Billion USD | 99.99% |
| Ember Therapeutics, Inc. | 184.00 USD | -179502.174% |
| Anthera Pharmaceuticals, Inc. | - USD | -Infinity% |
| Sigyn Therapeutics, Inc. | 321.8 Thousand USD | -2.692% |
| WPD Pharmaceuticals Inc. | 261.36 Thousand USD | -26.44% |
| Cotinga Pharmaceuticals Inc. | 927.96 Thousand USD | 64.388% |
| Kadimastem Ltd | 2.3 Million USD | 85.657% |
| Helix BioMedix, Inc. | 3.02 Million USD | 89.076% |
| VitaSpring Biomedical Co. Ltd. | - USD | -Infinity% |
| Capstone Therapeutics Corp. | 52.7 Million USD | 99.373% |
| BioStem Technologies, Inc. | 14.56 Million USD | 97.73% |
| Oncology Pharma Inc. | - USD | -Infinity% |
| Reve Technologies, Inc. | 57.09 Thousand USD | -478.814% |
| LadRx Corporation | 2.3 Million USD | 85.681% |
| Cell Source, Inc. | 195.17 Thousand USD | -69.322% |
| Regen BioPharma, Inc. | 353.61 Thousand USD | 6.546% |
| Regen BioPharma, Inc. | 353.61 Thousand USD | 6.546% |
| NovAccess Global Inc. | 62.24 Thousand USD | -430.889% |
| Affymax, Inc. | 7.44 Million USD | 95.56% |
| Itoco Inc. | 1.4 Million USD | 76.396% |
| Rasna Therapeutics, Inc. | 95.65 Thousand USD | -245.472% |
| Pathfinder Cell Therapy, Inc. | 106 Thousand USD | -211.762% |
| Mobile Lads Corp. | 52.00 USD | -635415.385% |
| CytoDyn Inc. | 11.13 Million USD | 97.032% |
| Claritas Pharmaceuticals, Inc. | - USD | -Infinity% |
| NDT Pharmaceuticals Inc. | 142.97 Thousand USD | -131.142% |
| NanoSphere Health Sciences Inc. | 17.88 Thousand USD | -1748.255% |
| Alseres Pharmaceuticals, Inc. | 385.47 Thousand USD | 14.269% |
| Advanced Proteome Therapeutics Corporation | - USD | -Infinity% |
| ImmunoCellular Therapeutics, Ltd. | 409.42 Thousand USD | 19.284% |
| International Stem Cell Corporation | 5.39 Million USD | 93.869% |
| Bioxytran, Inc. | 137.63 Thousand USD | -140.099% |
| GlobeImmune, Inc. | - USD | -Infinity% |
| Predictive Technology Group, Inc. | - USD | -Infinity% |
| ProText Mobility, Inc. | 15 Million USD | 97.797% |
| Cardax, Inc. | - USD | -Infinity% |
| VG Life Sciences Inc. | - USD | -Infinity% |
| Kaleido Biosciences, Inc. | - USD | -Infinity% |
| Advaxis, Inc. | 16.57 Million USD | 98.007% |
| Adhera Therapeutics, Inc. | 79 Thousand USD | -318.314% |
| RenovaCare, Inc. | - USD | -Infinity% |
| Regnum Corp. | 864.67 Thousand USD | 61.781% |
| Innovation Pharmaceuticals Inc. | 7.51 Million USD | 95.604% |
| Neutra Corp. | 2851.00 USD | -11491.301% |
| Windtree Therapeutics, Inc. | 32.4 Million USD | 98.98% |
| PureTech Health plc | 693.97 Million USD | 99.952% |
| Coeptis Therapeutics, Inc. | 8.07 Million USD | 95.906% |
| IXICO plc | 15.84 Million USD | 97.914% |
| IntelGenx Technologies Corp. | 8.28 Million USD | 96.01% |
| Gelesis Holdings, Inc. | 103.32 Million USD | 99.68% |
| CSL Limited | 38.02 Billion USD | 99.999% |
| Cellectis S.A. | 333.99 Million USD | 99.901% |